You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Patient demography and clinical status of the study participants

From: High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naïve perinatally-infected children and adolescents with HIV-1 subtype C infection

  Over all (n = 105) <5 years (n = 17) ≥5 to <10 years (n = 49) ≥10 years (n = 39)
Sex: Male (%) 61 (58.1%) 12 (70%) 29 (59%) 20(51%)
CD4-T cell count 530 (338–780) 1051 (528–1154) 586 (401–768) 373 (251–578)
Median (IQR*)
Viral load log copies/mL 5.24 (4.62-5.66) 5.56 (5.51-6.05) 5.12 (4.55-5.55) 5.2 (4.73-5.63)
Median (IQR*)
WHO Clinical stage
Stage 1 40 (38.1%) 6 (35.3%) 19 (38.7%) 15 (38.5%)
Stage 2 37 (35.2%) 5 (29.4%) 19 (38.7%) 13 (33.3%)
Stage 3 22 (21%) 4 (23.5%) 9 (18.4%) 9 (23.1%)
Stage 4 6 (5.7%) 2 (11.8%) 02 (4.1%) 2 (5.1%)
  1. *IQR: Inter-quartile range.